Silver Diamine Fluoride: A Randomized Controlled Trial on Its Effectiveness As A Caries Arresting Agent

  • STATUS
    Recruiting
  • End date
    Jul 9, 2023
  • participants needed
    132
  • sponsor
    Universiti Teknologi Mara
Updated on 9 July 2022
Accepts healthy volunteers

Summary

The aim of the study is to assess the effectiveness of 38% Silver Diamine Fluoride (SDF) solution and to determine if it is superior to 5% NaF varnish in arresting carious lesions in the primary teeth of young children attending general dental clinic, Universiti Teknologi Mara.

Hypothesis: Topical application of a 38% SDF solution on the primary teeth is superior to that of a 5% NaF varnish in arresting caries lesions in children at 3-months follow-up

An intervention study is planned to compare the effectiveness of 38% SDF and 5% NaF in arresting caries lesions in primary teeth of 3-8 years old children attending general dental clinic, Universiti Teknologi Mara. The sample size needed (considering a 20% dropout rate) is 66 participants in each group. In addition, this study also aims to determine the demographic background, oral health-related habits, oral health-related quality of life of the participants and the parents acceptance on SDF treatment towards their child.

Description

Convenience sampling will be used, in which patient will be recruited from General Dental Clinic (Sapphire), Faculty of Dentistry, Universiti Teknologi Mara. The total number of participants needed is 132. At baseline, during the screening and examination stage, apart from ICDAS score and the decayed, missing, and filled surface (dmfs) index to record each child's caries experience, recorded status will also include baseline bitewings of posterior teeth and DIAGNOdent reading (triplicate reading will be carried out to achieve accurate value) for all lesions. Periapical radiograph of anterior teeth will only be taken to confirm no pulp involvement when depth of lesion is questionable. Five tooth surfaces (buccal, lingual, mesial, distal and occlusal) will be examined in each posterior tooth and four tooth surfaces (labial, lingual, mesial and distal) in each anterior tooth. A carious lesion will be recorded as active if softness is detected upon gentle probing. If the lesion is hard when probing, it will be classified as an arrested caries. Screening and oral examination will be conducted on a dental chair in assigned clinic at Faculty of Dentistry, Universiti Teknologi Mara, primarily through careful visual inspection with the aid of a World Health Organization (WHO) CPI probe and a stainless steel/disposable front surface dental mirror by the main researcher. The main researcher will record each patient's caries status on a separate paper-based trial record at the beginning of the study in which she will not have the access to Integrated Dental Record Management System (IDERMS) in order to maintain blindness. Before conducting the study, a training and calibration session for oral examination (ICDAS and DIAGnodent utilization) is planned for the main researcher with one specialist in dental public health and one specialist in paediatric dentistry with the aim to achieve the kappa values of inter and intra-reliability ≥0.8.

Next, after the screening and before consent, if the child is eligible for the study, parents or guardians will be provided with information about SDF and NaF, follow-up instructions, oral hygiene instruction and diet education which will use video and pamphlet. Parents and guardians who agreed to participate in the study will be given questionnaire which include children's demographic background, oral-health related habits, and Malay- ECOHIS together with the information sheet and consent sheet. Appointment for first topical fluoride application will be given within one week from baseline oral examination day.

On the first appointment day, the allocation of patient between 38% SDF application and 5 % NaF application is randomized using sequentially numbered, opaque sealed envelopes (SNOSE) procedure (Doig & Simpson, 2005). Block of four and six will be used to ensure that similar numbers of patients are enrolled into each group and to ensure the prediction of allocation sequence impossible. The order of the blocks will be determined by flipping a coin. This will be carried out by a dental officer/postgraduate student who is not involved with the study. He/she will keep the piles of blocks and when participant comes for the intervention, he/she will ask the operator to select one envelope from the first pile of blocks according to allocated sequence and will prepare the treatment selected. After first application is completed, he/she also will be the one who will update the Integrated Dental Record Management System (IDERMS) on which treatment has been used for the respective participants in order for him/her to prepare the same treatment for the 1-month follow up. The topical fluoride applications will be carried out by the other three researchers who are not involved in the screening and assessing of the lesion activity. Before the study, they will be trained by a paediatric dental specialist who is not involved in the study for the clinical application procedure. This is a double-blind clinical trial where the main researcher is not aware of which treatment the participants will be receiving, the other researchers are not aware which treatment they are providing and participants are not aware of which treatment they are receiving.

Participants will be called again for second application of same treatment they received on the first appointment after one month. Final appointment follow-up examination will be given at three months after first application of the topical fluoride. Same examiner will conduct the follow-up oral examinations using the same equipment, procedure and diagnostic criteria as those used in the baseline examination. Another questionnaire inclusive of parental acceptability for SDF treatment on their children and OHRQoL (Malay-ECOHIS) will be distributed to the same parents or guardians and will be asked to complete the questionnaire survey. After study is completed, the participants will be assigned back to undergraduate students for definitive treatment.

Details
Condition Dental Caries, Quality of Life
Treatment 38% SDF group, 5% NaF group
Clinical Study IdentifierNCT05008718
SponsorUniversiti Teknologi Mara
Last Modified on9 July 2022

Eligibility

Yes No Not Sure

Inclusion Criteria

Three to eight years old children. The reason for selecting children up to eight years old is because there are still patients aged seven to eight years old who presented with posterior deciduous teeth and upper lateral incisor deciduous teeth caries. Children below three years old are not included in order to obtain better cooperation from the participants
Children who are generally healthy, not medically compromised
Children who have at least one active carious lesion on a deciduous tooth which include upper anterior teeth caries (c-c) with a minimum score of 05 as defined by the International Caries Detection and Assessment System (ICDAS)
Provision of informed consent by the parent or guardian

Exclusion Criteria

Children with spontaneous or elicited pain from caries, tooth mobility, or signs of pulpal infection
Children with severe medical conditions that would not allow management in the clinic
Children with hereditary developmental defects, such as amelogenesis imperfecta
Children with known allergies or sensitivities to dental materials, including silver diamine fluoride and sodium fluoride
Inability to cooperate for silver diamine fluoride treatment or return for recall visits 3 months
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note